Zebrafish as a preclinical model for Extracellular Vesicle-based therapeutic development.

Adv Drug Deliv Rev

Université de Paris, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, F-75014 Paris, France; GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, F-75014 Paris, France. Electronic address:

Published: September 2021

Extracellular Vesicles (EVs) are released during various pathophysiological processes and reflect the state of their cell of origin. Once released, they can propagate through biological fluids, target cells, deliver their content and elicit functional responses. These specific features would allow their harnessing as biomarkers, drug nano-vehicles and therapeutic intrinsic modulators. However, the further development of their potential therapeutic application is hampered by the lack of knowledge about how EVs behave in vivo. Recent advances in the field of imaging EVs in vivo now allow live-tracking of endogenous and exogenous EV in various model organisms at high spatiotemporal resolution to define their distribution, half-life and fate. This review highlights current imaging tools available to image EVs in vivo and how live imaging especially in the zebrafish embryo can bring further insights into the characterization of EVs dynamics, biodistribution and functions to potentiate their development for therapeutic applications.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.addr.2021.05.025DOI Listing

Publication Analysis

Top Keywords

evs vivo
8
evs
5
zebrafish preclinical
4
preclinical model
4
model extracellular
4
extracellular vesicle-based
4
therapeutic
4
vesicle-based therapeutic
4
therapeutic development
4
development extracellular
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!